Diao, Xiaotong http://orcid.org/0000-0001-8449-6688
Ye, Fei http://orcid.org/0000-0003-4119-3219
Zhang, Meina
Ren, Xintong
Tian, Xiaoxu
Lu, Jingping
Sun, Xiangnan
Hou, Zeng
Chen, Xiaoyu
Li, Fengwei
Zhuang, Jingjing
Ding, Hong
Peng, Chao http://orcid.org/0000-0002-6814-2676
Rastinejad, Fraydoon
Luo, Cheng http://orcid.org/0000-0003-3864-8382
Wu, Dalei http://orcid.org/0000-0003-1817-7229
Funding for this research was provided by:
National Natural Science Foundation of China (22177063)
Natural Science Foundation of Shandong Province (ZR2021JQ30)
Article History
Received: 3 November 2021
Accepted: 26 April 2022
First Online: 9 May 2022
Competing interests
: F.R. is a founder and consultant for Flare Therapeutics. The remaining authors declare no competing interests.